- Exchange: New York
- Sector: Consumer, Non-cyclical
- Industry: Healthcare-Products
- Sub-Industry: Diagnostic Kits
Snapshot for Alere Inc (ALR)
| Open: | 26.2800 | Day's Range: | 26.0100 - 26.5600 | Volume: | 560,180 |
|---|---|---|---|---|---|
| Previous Close: | 26.1900 | 52wk Range: | 17.1300 - 29.5700 | 1-Yr Rtn: | +41.40% |
Key Statistics for ALR
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(12/2013) | 11.9058 |
| Relative P/E vs. SPX | - |
| Earnings Per Share (USD) (ttm) | -0.7600 |
| Est. EPS (USD) (12/2013) | 2.2090 |
| Est. PEG Ratio | 1.1906 |
| Market Cap (M USD) | 2,137.89 |
| Shares Outstanding (M) | 81.29 |
| 30 Day Average Volume | 702,148 |
| Price/Book (mrq) | 1.5130 |
| Price/Sale (ttm) | 0.7362 |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 08/08/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for ALR
Company Profile & Key Executives for ALR
Alere, Inc. offers patient diagnosis, monitoring and health management services. The Company produces consumer and professional medical diagnostic products, and remotely monitors patients for pre-eclampsia, and patients who are prescribed Warfarin for atrial fibrillation.
| Ronald Zwanziger "Ron"Chairman/President/CEO | Namal NawanaChief Operating Officer |
| Gordon NormanChief Innovation Officer | David ScottChief Scientific Officer |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
ALR News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page